Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
ExCentric: Cilengitide with Chemoradiotherapy in Unmethylated Glioblastoma
NCT01124240Phase 2Unknown
- Sponsor
- Northern Sydney and Central Coast Area Health Service
- Start
- Nov 2009
- Primary completion
- Nov 2012
- Countries
- 1
01
Overview
A Phase 2 trial of cilengitide in glioblastoma multiforme (GBM), sponsored by Northern Sydney and Central Coast Area Health Service. Status: unknown.
02
Drugs
cilengitide
03
Conditions
glioblastoma multiforme (GBM)
Beyond the preview
Go deeper on NCT01124240.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01124240.